Institutions / JW Asset Management, LLC

JW Asset Management, LLC

CIK 1549738 · Institutionalso an insider · as of Jun 30, 2026
Portfolio value
$319.87M
Positions
21
As of
Jun 30, 2026

Portfolio trend

Portfolio value

$319.87M+4.1%
$319.87M$313.54M$307.21MQ4 '25Q2 '26

Positions

21+16.7%
212018Q4 '25Q2 '26

Top holdings

Jun 30, 2026
CompanyClassValueShares% of portfolio
Establishment Labs Holdings Inc.—$231.07M2,692,85672.2%
Sandisk Corp—$17.76M7,8105.6%
Vita Coco Company, Inc.—$14.46M218,6214.5%
Catalyst Pharmaceuticals, Inc.—$12.21M388,3923.8%
Micron Technology Inc—$8.08M7,0002.5%
Iren Limited—$6.61M144,6502.1%
Idaho Strategic Resources Inc—$4.62M141,1971.4%
Ralph Lauren Corp—$4.01M10,0001.3%
Cava Group, Inc.—$3.92M50,0001.2%
NVIDIA Corp—$3.05M15,2501.0%
On Hldg AG—$2.58M72,9500.8%
Five Below Inc—$1.80M10,0000.6%
Travere Therapeutics, Inc.—$1.70M30,0000.5%
Heron Therapeutics, Inc. /De—$1.60M3,751,0730.5%
Dell Technologies Inc.—$1.51M3,5000.5%
Ligand Pharmaceuticals Inc—$1.26M4,0000.4%
Marvell Technology, Inc.—$953.2K3,2000.3%
Trulieve Cannabis Corp—$824.4K83,8690.3%
Liquidia CorpLQDACommon Stock$811.3K10,1760.3%
Advisorshares Tr—$787.4K155,0000.2%
High Tide Inc—$220.3K96,6430.1%

Activity

Jun 30, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q2 2026
as of
TrimEstablishment Labs Holdings Inc.
Common stock
$-31.65M-369K
-12.05%
2,692,856
72.24% of portfolio
medium
Q2 2026
as of
NewSandisk Corp
Common stock
$17.76M+8K
7,810
5.55% of portfolio
medium
Q2 2026
as of
ExitRobinhood Markets, Inc.
Common stock
$-10.86M-96K
-100.00%
0
medium
Q2 2026
as of
ExitAlphabet Inc.
Common stock
$-8.64M-28K
-100.00%
0
medium
Q2 2026
as of
NewMicron Technology Inc
Common stock
$8.08M+7K
7,000
2.53% of portfolio
medium
Q2 2026
as of
TrimLQDA
Liquidia Corp
Common Stock
$-7.14M-90K
-89.80%
10,176
0.25% of portfolio
medium
Q2 2026
as of
ExitMeta Platforms Inc
Common stock
$-5.74M-9K
-100.00%
0
medium
Q2 2026
as of
TrimH5919C104
Common stock
$-2.23M-63K
-46.34%
72,950
0.81% of portfolio
low
Q2 2026
as of
NewTravere Therapeutics, Inc.
Common stock
$1.70M+30K
30,000
0.53% of portfolio
low
Q2 2026
as of
NewDell Technologies Inc.
Common stock
$1.51M+4K
3,500
0.47% of portfolio
low

Insider transactions

Also files Forms 3 / 4 / 5
DateActionCompanyValueShares ΔPosition afterImpact
May 28, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$4.75M-65K
-2.20%
2,890,582
9.70% of shares
medium
May 6, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$4.54M-60K
-1.96%
3,001,694
10.07% of shares
medium
May 26, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$1.88M-25K
-0.85%
2,955,795
9.92% of shares
medium
May 21, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$1.21M-17K
-0.57%
2,981,115
10.00% of shares
medium
May 20, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$252.6K-4K
-0.12%
2,998,114
10.06% of shares
medium
May 27, 2026SellESTA
Establishment Labs Holdings Inc.
Common Shares
$8.2K-113
-0.00%
2,955,682
9.92% of shares
low
Jun 24, 2026GrantTSNDF
TerrAscend Corp.
Employee Share Option (Right to Buy)
—+1.0M
1,000,000
0.32% of shares
low
Jun 24, 2026OtherTSNDF
TerrAscend Corp.
Employee Share Option (Right to Buy)
—-1.0M
-100.00%
0
0.00% of shares
low
Jun 24, 2026GrantTSNDF
TerrAscend Corp.
Employee Share Option (Right to Buy)
—+200K
200,000
0.06% of shares
low
Jun 24, 2026OtherTSNDF
TerrAscend Corp.
Employee Share Option (Right to Buy)
—-200K
-100.00%
0
0.00% of shares
low